chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Shortness of breath, fast heartbeat while exercising. I exercise everyday and am exercise instructor. This was not normal. Asked a friend to monitor me for a few minutes while I sat down and relaxed. Shortness of breath continued through-out the evening. Next morning no apparent problems.
This spontaneous report as received from a nurse refers to a 12 years old patient (unknown gender). No concurrent condition, medical history or allergy/drug reactions were reported. On 03-JUN-2015, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) GARDASIL injection, dose number 3, lot # K006960, exp. date: 19-FEB-2017 (dose, strength and route unspecified). No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
Pt presents to the ED today with c/o room spinning dizziness beginning while at work today about 1 hour PTA with associated HA. After onset she reports that she drank a cup of warm water but still felt dizzy. Pt reports that she received the Pfizer vaccine on January 4th. Pt denies CP and SOB at this time. Vertigo onset 9 days after receiving first dose of Pfizer C19 vaccine. Duration several hours, resolved spontaneously. Likely BPPV.
Patient received Bi Valent form instead of gray cap as fist dose. note Manufacture will be DC old form and Have 2nd short set as bivalent. Second dose given as Bivalent form by Nurse.
Very tired, muscle and "bone" ache, nausea. significant site of injection pain. Started about 6-7 hours after vaccination and lasting over 36 hours. for 24 hours at least difficulty getting out of bed, loss of appetite  but no vomiting.
Patient received Varivax 0.5 cc SQ left arm on 8/26/02. On 9/12/02 developed reddened area (15mmx15mm) lymphandenopathy right auricular area, 8-10 vesicles left trunk and back, 2 lesions inner lower lip. No fever.
Patient did not have an adverse event. the patient was supposed to be given the 2nd dose of Pfizer but was accidentally given the Janssen vaccine instead. patient had no adverse reactions and pfizer stated that the cdc states janssen can be given to those that do not tolerate the 1st dose of pfizer so medical issues do not seem to be a concern. also j&j stated they are going to approve this vaccine being to individuals less than 18 years old and they do not see a safety issue with this event
Information has been rec'd for diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid (Infanrix) and hepatitis B vaccine recombinant (Engerix-B) and concerns a 2 month old infant who on 11/15/01 was vaccinated with one dose of haemophilus B conjugate vaccine (manufacturer unknown). concomitant vaccinations that day included one dose each of poliovirus vaccine (IPOL), hepatitis B vaccine, recombinant (Engerix-B) and diphtheria toxoid/  pertussis vaccine/tetanus (Infanrix. Within 5 min. post vaccination the infant began crying, turned blue, appeared to either fall asleep or pass out, and developed a rash on the face and body. The infant was observed in the physicians office for 2 hrs. The rash lasted 1.5 hrs. The other events had also resolved and the infant was sent home. The reporting physician considered the events to be related to the diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid (Infanrix) and hepatitis B vaccine recombinant (Engerix-B). The pt's experience were considered to be other important medical events. Additional information has been requested. Other business partner numbers include F2002-00175 and U2002-00035.
Breakthrough case admission after 3 vaccines Pfizer 1/19/21 Lot# El3249;  Pfizer 2/9/21 Lot# EM9810;  8/17/21 Pfizer lot# EW0173;
Tdap given to age >64.  TDAP vaccine given age inappropriately to client age 70.  Vaccine was well tolerated per clients report.
Low grade fever vomiting, diarrhea. Moderate to severe abd cramping, was treated at ER with IV fluids.
On 03/10/2023 I was experiencing sore throat, headache and congestion. I tested positive for Covid-19. After reaching out to health care provider I was prescribed molnupiravir for 5 days. Symptoms lasted a week.
Patient received undiluted dose of Pfizer, 150mcg on 10/28/2021 (booster dose). On 10/29/2021, patient reported sore arm but otherwise felt well. Took ibuprofen 600-800mg every 8 hours as needed with good relief. 10/30/2021, patient reported diffuse muscle ache, but much improved from previous day. 11/2/2021, patient reported all symptoms completely resolved.
On 2/22/2022 pt. came in for third vaccine, with two previous Pfizer Vaccines given at our COVID Clinic.  After pt. left, it was discovered that the pt. received a Pediatric Pfizer Covid-19 Vaccine ( 0.2 mls).
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 16-DEC-2009, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 20-OCT-2011, the patient was treated by a hospital for a blistering vesicular outbreak, which was diagnosed as herpes zoster, or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
VARICELLA GIVEN SQ IN LEFT UPPER ARM 2 DAYS AGO (8/6/08. PRESENTS TODAY WITH 35MMX 55MM RED CIRCLE AND 25MMX35MM INDURATION WITHIN THE CIRCLE. DENIES ITCHING OR SCRATCHING. + WARMTH TO TOUCH. ANTIBIOTIC GIVEN BY PROVIDER FOR CELLULITIS.  KEFLEX 500MG TID X 10 DAYS
COVID-19 treatment; COVID-19 treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 04Oct2022 as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19 treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Both shot one and two gave me the same symptoms, low grade fever, muscle aching. slight headache, upset stomach and low energy. It has only been  24 hours since the second shot so I do not know how long these symptoms will last  After the first shot I felt sick for 3-4 days. The site of shot becomes red within six hours and the next day there is blotchy redness in an area about three inches circle below the original shot. That area is hot and sore feels tight. This red and blotchy area lasted a long time after the first shot, maybe two weeks and would get red again when I took a bath.  The first time I did show my pharmacist otherwise I did not seek treatment.
Tdap given on 8/28, 8/29 noted increased pain (L) upper arm. Seen on 9/2, 9 cm area of erythema with induration started on BACTRIM for possible cellulitis. Re-eval on 9/4 - sx resolved.
On 23 April 2008, member felt nauseous around midnight.  Member began feeling joint pains in legs/hips and overall aches.  At 1000 on 24 April 2008 member's temp. was 99.9 F at 1200 temp. went up to 101.0F and at 1400 on 24 April 2008 it was 101.9F. Member began to take ibuprofen same day and the fever broke around 2000.  Site of injection swollen and red about 1-1 1/2 inch diameter area.
This is a spontaneous report from a contactable physician via sales representative. A patient of unspecified age ethnicity and gender started to received PREVNAR 13, via an unspecified route of administration on an unspecified date at 0.5 ml, single. Medical history included myeloma. the patient's concomitant medications were not reported. The patient experienced 4 episodes of inflammatory cellulitis on an unspecified date with outcome of unknown.
Arm was sore the first evening. The following day it was inflamed, very swollen, red/hot to touch, and ached with every movement. This continued, but on June 26th the swelling went down some. The 27thit has subsided, could sleep on that side for a while last night.
injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (injection site pain) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID], CARVEDILOL, ATORVASTATIN CALCIUM, LISINOPRIL and AMLODIPINE for an unknown indication.    On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (injection site pain). At the time of the report, INJECTION SITE PAIN (injection site pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   treatment to the events not reported.   This case was linked to MOD-2021-369033 (Patient Link).
Information has been received through a pregnancy registry concerning a 14 year old black female with no past medical history and no allergies who on 11/28/01 was vaccinated with a dose of varicella virus vaccine live (site unknown). There was no concomitant medication. On 12/12/01 it was reported that the pt was eight weeks pregnant (LMP: 10/3/01). The pt had no previous pregnancies. It was also noted that there was no local reaction at the vaccination site. It was reported to be unknown if the pt was tested for varicella antibodies before vaccination. The pt sought unspecified medical attention. Follow-up info reported that on 1/23/02, 16 weeks from LMP, there was an elective termination of the pregnancy. It was reported to be unknown if the fetus was normal. No further information is available.
Fever-continued General Aching-continued Cough-continued Diarrhea-continued Loss of Appetite-continued Headache-continued
This pt came in to see me in her normal state of health and then received moderna #1 here on 4/1.  Developed SOB 2 hrs after vaccination. Presented to ER on 4/2 with hypoxia (80%) and was + for covid.  The ER triage notes states ?C/O SOB, Nausea, vomiting, diarrhea that started yesterday 2 hours after he first COVID Vaccine?.  Notes quote her saying ?I got my vaccine yesterday and I started to feel short of breath.? She died from covid respiratory failure on 4/23.
child admitted to CHOC dx with Kawasaki Disease on 7/10/2007. 10/29/07-records received for DOS 07/10-07/13/07-DC DX: Kawasaki disease. Seen in ER temperature 104.4,  Admitted with fever, rash and swollen extremities, chapped lips, decreased oral intake began last Friday. Conjuctivial injection bilaterally,  Treated with IVIG.
I ached all over just as if I had the flu. My arm was so sore I could hardly lift it & if I touched it it killed me.
This spontaneous report as received from a nurse who at the physician's office via a company representative, stated that they would no longer order VAQTA pediatric doses, (Lot# unspecified) dose, frequency and route unspecified, because this vaccine's caps were the same color as SANOFI's flu vaccines, and the physician's office stated they were afraid of mixing the products up. No adverse effects occurred. This is one of several reports received from the same reporter. Additional information has been requested.
so bad I couldn't sit or stand or anything; couldn't sleep; chills; muscle pain; joint pain; This is a spontaneous report from a contactable consumer (the patient). A female patient of an unspecified age received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot #: UNKNOWN), via an unspecified route of administration on 13Feb2021 as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient reported that after the vaccination she had had all the reactions except 2. On 15Feb2021, the patient experienced couldn't sleep, chills, muscle pain, joint pain. She reported that on 16Feb2021 her symptoms were so bad that "I couldn't sit or stand or anything". Therapeutic measures were taken as a result of chills, muscle pain, joint pain, so bad i couldn't sit or stand or anything. She took Tylenol to treat her symptoms, and the next day they were resolved. The clinical outcome of the events chills, muscle pain, joint pain, so bad i couldn't sit or stand or anything was recovered. The clinical outcome of the remaining event was unknown.   Information about lot number has been requested.
wheezy; sob along with diaphoresis; shortness of breath; This is a spontaneous report from a non-contactable other healthcare professional. A 60-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch number: ER8727) via unspecified route of administration on 24Mar2021 (at the age of 60-years-old) as a single dose for Covid-19 immunisation. Medical history included asthma. Concomitant medications were not reported. During the 15 minutes waiting period after the injection the patient did fine. However, patient noted to be sitting on side after pushing his sister in wheelchair to take a "break." On 24Mar2021, the patient experienced wheezy, sob along with diaphoresis and shortness of breath. Patient had history of asthma and had forgot to bring inhalers. Patient does not walk much and was a long walk today and was offered a wheelchair and was brought to the bay for inhaler treatment. Patient denied rash, hives, welts, difficulty swallowing, throat tightness, hoarseness, stridor, itching, light-headedness, dizziness, facial swelling, lip swelling and tongue swelling. Therapeutic measures were taken as a result of wheeziness, diaphoresis and shortness of breath which include treatment with albuterol. The clinical outcome of wheeziness, diaphoresis and shortness of breath were unknown.   No follow-up attempts are possible. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: 1. patient's last name updated. 2. Country added in patient tab.  3. leading sentence updated to a non-contactable other healthcare professional. Reported Event: During his 15 minute waiting period after the injection he did fine. However, pt noted to be sitting on side after pushing his sister in wheelchair to take a "break." He was noted to be wheezy and sob along with diaphoresis. Pt states he has hx of asthma and forgot to bring his inhalers. He normally doesn't walk much anyway and today was a long walk. He was offered a wheelchair and brought to the bay for inhaler treatment. He denied rash, hives, welts, difficulty swallowing, throat tightness, hoarseness, stridor, itching, lightheadedness, dizziness, facial swelling, lip swelling and tongue swelling. Patient complains of shortness of breath and wheezing Treatment included: albuterol
I did not feel good in general; I lost a couple of pounds; my appetite wasn't up the part; arm was a little bit sore to the touch; pretty fast heartbeat/irregular heartbeat; slight fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was a little bit sore to the touch), PALPITATIONS (pretty fast heartbeat/irregular heartbeat), MALAISE (I did not feel good in general), WEIGHT DECREASED (I lost a couple of pounds) and DECREASED APPETITE (my appetite wasn't up the part) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced PYREXIA (slight fever). On 27-Feb-2021, the patient experienced PALPITATIONS (pretty fast heartbeat/irregular heartbeat). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm was a little bit sore to the touch), MALAISE (I did not feel good in general), WEIGHT DECREASED (I lost a couple of pounds) and DECREASED APPETITE (my appetite wasn't up the part). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 28-Feb-2021, PYREXIA (slight fever) had resolved. At the time of the report, PAIN IN EXTREMITY (arm was a little bit sore to the touch), PALPITATIONS (pretty fast heartbeat/irregular heartbeat), MALAISE (I did not feel good in general), WEIGHT DECREASED (I lost a couple of pounds) and DECREASED APPETITE (my appetite wasn't up the part) outcome was unknown.            Action taken with mRNA-1273 in responsible to the events were not applicable no relevant concomitant medications was reported.   This case was linked to MOD-2021-030380 (Patient Link).
administered expired dose of the Moderna COVID-19 vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered expired dose of the Moderna COVID-19 vaccine) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028K21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 20-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 20-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered expired dose of the Moderna COVID-19 vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered expired dose of the Moderna COVID-19 vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  The vaccine provided administer expired vaccine to the patient at a local jail. The vial was initially stored in the refrigerator was on 09-May-2022. The vial did not undergo any temperature excursions.  The patient did not report any adverse reactions to this expired dose.  No treatment information was provided by the reporter.
2 days after DPT and IPV given to left deltoid, swelling and deep redness around site of shot (1.5 ") that extended down to elbow by the fourth day and started to regress after that. No fever or systemic symptoms. Patient seen on day 5 after vaccines given.
pt exp foot infect w/white blisters;pt was seen by many specialists;MD reported 22SEP95 (96?) c/o was enlarged & painful backs of both heels;pt exp pain when back heel pulled & when walked;dx poss rheumatoid arthritis;bursitis;discoloration
Initial report received on 20 November 2009 from a health care professional. A male patient with no reported medical history developed a blood glucose level of 300 three to four days after he received an influenza vaccine (manufacturer and lot not reported) in 2008. Prior to vaccination the patient's blood glucose level was 110. The recovery status and further details were not reported. List of Documents held by Sender: none.
LIGH HEADED Narrative: 1219: LIGHT HEADED FOR 30 SEONDS, LAID SELF ON THE FLOOR 127/84 88 RA 96% RESOLVED @ 1246 115/75 98 18 97% RA NO INTERVENTIONS
Patient developed sudden onset SOB and chest pain within 12 hours of s\p vaccination. Her son called 911- she was in ER for 4-5hrs and ER staff told her this was vaccine related. Patient will not receive dose #2
No additional AE reported; an improperly stored dose of PROQUAD was administered today; The patient was suppose to receive MMR II but the PROQUAD was inadvertently administered instead.; The patient was suppose to receive MMR II but the PROQUAD was inadvertently administered instead.; This spontaneous report was received from a nurse practitioner and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history and drug reactions or allergies was provided.  On 30-JUN-2021, the patient was inadvertently vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) recombinant human albumin (rHA), lot # T036562, expiration date 26-APR-2022, 1 injection for prophylaxis (exact dose, anatomical location and route of administration were not reported) instead of planned measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II). Concomitant therapies included varicella virus vaccine live (oka/merck) (VARIVAX) administered on the same day (lot # T032316, expiration date 22-SEP-2022) for prophylaxis.   Digital Data logger was not involved. The measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was stored at the temperature that was reported as from 14 degrees of Fahrenheit to 46 degrees of Fahrenheit (42.9 degrees of Fahrenheit) for 336 hours. There was no previous temperature excursion reported.  No additional adverse event reported.
Pt recived the third Moderna vaccine on 11/2/21. She came to ER due to SOB, cough, and fever 102.6 on 1/10/23. She was tested positive COVID PCR on 1/10/23 and admitted for further evaluation. Next day, her CT chest demonstrated a large pericardial effusion with impending tamponade, so she was transferred to ICU unit, where cardiac window was performed on 1/12/23. She was also found out large pleural effusion and had PleurX catheter placed. She recieved 5 days of remodesivir and steroid. Both pericardial and pelural fluids showed adnocarcinoma. She was medically stable and discharged home on 1/15/23.
Immediately after injection of vaccination her left deltoid started swelling. Complains of pain at injection site. No other complaints. Applied ice. She took Tylenol and Benedryl. Stayed 30 minutes after vaccination without further complaint.